Healthstream Misses Where it Counts

Seth Jayson, The Motley Fool
Updated

Healthstream (NAS: HSTM) reported earnings on Oct. 22. Here are the numbers you need to know.

The 10-second takeaway
 For the quarter ended Sep. 30 (Q3), Healthstream beat expectations on revenues and missed estimates on earnings per share.

Compared to the prior-year quarter, revenue grew significantly and GAAP earnings per share dropped.


Gross margins dropped, operating margins increased, net margins dropped.

Revenue details
 Healthstream chalked up revenue of $26.4 million. The four analysts polled by S&P Capital IQ foresaw revenue of $25.6 million on the same basis. GAAP reported sales were 28% higher than the prior-year quarter's $20.6 million.

Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.

EPS details
 EPS came in at $0.07. The four earnings estimates compiled by S&P Capital IQ forecast $0.09 per share. GAAP EPS of $0.07 for Q3 were 13% lower than the prior-year quarter's $0.08 per share.

Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.

Margin details
 For the quarter, gross margin was 59.0%, 260 basis points worse than the prior-year quarter. Operating margin was 14.1%, 100 basis points better than the prior-year quarter. Net margin was 7.5%, 120 basis points worse than the prior-year quarter.

Looking ahead
 Next quarter's average estimate for revenue is $26.7 million. On the bottom line, the average EPS estimate is $0.10.

Next year's average estimate for revenue is $101.7 million. The average EPS estimate is $0.33.

Investor sentiment
 The stock has a two-star rating (out of five) at Motley Fool CAPS, with 74 members out of 84 rating the stock outperform, and 10 members rating it underperform. Among 20 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 15 give Healthstream a green thumbs-up, and five give it a red thumbs-down.

Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Healthstream is outperform, with an average price target of $27.50.

The article Healthstream Misses Where it Counts originally appeared on Fool.com.

Seth Jayson had no position in any company mentioned here at the time of publication. You can view his stock holdings here. He is co-advisor ofMotley Fool Hidden Gems, which provides new small-cap ideas every month, backed by a real-money portfolio. The Motley Fool has no positions in the stocks mentioned above. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Copyright © 1995 - 2012 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

Advertisement